Answers are grounded in this paper and cite their sources.
Lu-rhPSMA-10.1 shows a favorable tumor-to-kidney uptake ratio, and significant antitumor effects, indicating it to be a promising next-generation radiopharmaceutical therapy.
No takes yet. Share an insight, caveat, or question.
Foxton et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: